2TANIGUCHI T,KOBAYASHI T,KONDO J,et aI. Molecular cloning of a porcine gene Syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis [J]. J Biol Chern, 1991 , 266 (24) : 15790 - 15796.
3RICCABONI M, BIANCHI I, PETRILLO P. Spleen tyrosine kinases , biology, therapeutic targets and drugs [J]. Drug Discov Today, 2010, 15 ( 13/14) : 517-530.
4KELLY V, GENOVESE M. Novel small molecule therapeutics in rheumatoid arthritis [J]. Rheumatology,2013,52(7) :1155 -1162.
5ARIAS-PALOMO E, RECUERO-CHECA M A, BUSTELO X R, et aI. Conformational rearrangements upon Syk auto-phosphorylation [J]. BBA-Proteins Proteom,2009,1794(8) :1211 -1217.
6YANAGIS,INATOMER,TAKANOT,etai. Syk expression and novel function in a wide variety of tissues [J]. Biochem Biopharm Res Communj Ztlll'l , 288(3) :495 -498.
7KLEINAU S, MARTINS SON P, HEYMAN B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcgamma receptors [J]. J Exp Med,2000,191(9) :1611-1666.
8LI B-K, CONG Y, YANG X G, et al. In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method [J]. Comput BioI Med, 2013 ,43 (4) :395 -404.
9MELTZER E O,BERKOWITZ R B,GROSSBARD E B. An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment [J]. J Allergy Clin Immun, 2005 , 115(4) :791 -796.
10PINE P R, CHANG B, SCHOETTLER N, et aI. Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor [J]. Clin Immunol, 2007 , 124 (3) :244 -257.
